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 Novel sensorimotor integration, a cortical silent period and their interaction were 
demonstrated in shoulder primary motor cortex in healthy adults. 
 Cortical neurophysiology was aberrant in patients with chronic shoulder pain. 
 Suprascapular nerve block injection immediately normalised sensorimotor integration 
and reduced pain while further modulation of the CSP by sensory input was apparent 





Objective: To characterise short afferent inhibition (SAI) and the cortical silent period (CSP) 
in primary motor cortex representations of the infraspinatus muscle in healthy adults and 
people experiencing chronic shoulder pain, to determine the impact of suprascapular nerve 
block (SSNB).  
Methods: Neurophysiological measures were obtained in 18 controls and 8 patients with 
chronic shoulder pain, pre and post SSNB and one week later. Pain intensity was assessed by 
a visual analogue scale. 
Results: SAI was observed in controls (all P < 0.03) and there was a CSP which reduced in 
the presence of SAI (all P < 0.0001). Compared to controls, shoulder pain patients 
demonstrated higher active motor threshold (P = 0.046), less SAI (P = 0.044), a longer CSP 
(P = 0.048) and less modulation of the CSP by SAI (P = 0.045). Higher motor thresholds 
were related to higher pain scores (P = 0.009). The SSNB immediately restored SAI (P = 
0.013), with a positive relationship between increased SAI and reduced pain (P = 0.031). The 
SSNB further reduced modulation of CSP by SAI at one week post injection (P = 0.006).   
Conclusions: SAI and the CSP were present and demonstrated robust interaction in controls, 
which was aberrant in patients. The SSNB transiently restored SAI but had no effect on the 
CSP; however CSP modulation by SAI was further attenuated one week post injection.   
Significance: The current findings improve understanding of shoulder motor cortex 
neurophysiology, its modulation by chronic pain and the effect of SSNB.  Interventions that 
target cortical inhibition might increase efficacy for chronic shoulder pain.  
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Chronic shoulder and upper limb pain is a highly prevalent and recalcitrant condition 
affecting health-related quality of life in many patient populations (Pope et al., 1997, Hill et 
al., 2010, Gill et al., 2013). There is emerging evidence that painful musculoskeletal disorders 
of the upper limb are accompanied by aberrant cortical neurophysiology (Krause et al., 2004, 
Krause et al., 2006, Alexander, 2007, Berth et al., 2009, Berth et al., 2010, Schabrun et al., 
2014). It is unclear whether this aberrant neurophysiology normalises in response to 
interventions targeting upper limb pain. If so, cortical measures might provide intervention 
targets and useful markers for the impact of treatments targeting pain. A suprascapular nerve 
block (SSNB) has shown efficacy for rheumatologic (Shanahan et al., 2003, Shanahan et al., 
2004) and post-stroke shoulder pain (Adey-Wakeling et al., 2013), with high patient 
acceptability and few adverse effects (Shanahan et al., 2012, Shanahan and Smith, 2012). The 
mechanisms contributing to the clinical efficacy of SSNB are unclear, but might arise from 
modification of cortical networks innervating shoulder musculature. It is well known that 
sensory input influences excitability of cortical networks by modulating intracortical 
connections within primary motor cortex (M1) (Chen et al., 1999, Tokimura et al., 2000). 
Furthermore, an ischemic nerve block produces rapid cortical reorganisation and increases 
corticomotor excitability in upper limb M1 representations in healthy adults (Brasil-Neto et 
al., 1993). An investigation into the effect of SSNB on cortical mechanisms is hampered by 
limited knowledge of neurophysiology of proximal upper limb muscles. The infraspinatus 
muscle is an important dynamic stabiliser of the shoulder, active throughout all shoulder 
movements (Arwert et al., 1997). Motor control of the infraspinatus is degraded in painful 
musculoskeletal conditions (Magarey and Jones, 2003). The cortical representations of 
infraspinatus have been mapped (Ngomo et al., 2013) and its task-dependent neural control 
investigated in healthy adults using transcranial magnetic stimulation (TMS) (Roberts et al., 
2008, Bradnam et al., 2010b). A study of infraspinatus cortical neurophysiology in people 
with chronic rotator cuff tears revealed higher active motor thresholds in M1 contralateral to 
the painful shoulder compared to the non-painful side (Ngomo et al., 2014), with thresholds 
related to pain duration. Cortical maps and corticomotor excitability were similar between 
hemispheres in these chronic shoulder pain patients.  
 
Intracortical mechanisms contributing to aberrant cortical neurophysiology in people 
experiencing shoulder pain can be explored using TMS. One method with potential relevance 
is known as short afferent inhibition (SAI). SAI is the result of inhibition of corticomotor 
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excitability by sensory input and is assessed by pairing TMS and peripheral nerve 
stimulation. Short AI was originally described in hand motor cortex following stimulation of 
the median nerve at the wrist (Tokimura et al., 2000). The SAI pathway is only partially 
elucidated, but is likely to traverse from the periphery directly to the thalamus and M1 
(Tokimura et al., 2000), via primary somatosensory cortex (SI) (Tsang et al., 2014). It is 
known that SAI is reliant upon cholinergic mechanisms (Di Lazzaro et al., 2000, Sailer et al., 
2003) interacting with γ-amino butyric acid (GABA) inhibitory interneurons (Di Lazzaro et 
al., 2005). Afferent inhibition is deficient in neurological disorders including stroke (Di 
Lazzaro et al., 2012), Alzheimer’s disease (Di Lazzaro et al., 2002) and Parkinson’s disease 
(Sailer et al., 2003, Yarnall et al., 2013). In contrast, SAI is normal in complex regional pain 
syndrome affecting the hand (Turton et al., 2007). There has been limited use of TMS to 
measure SAI outside of hand motor cortex; accordingly SAI in chronic shoulder pain has not 
yet been investigated. We recently described suppression of corticomotor excitability of 
infraspinatus by stimulation of the suprascapular nerve (Hendy et al., 2014), facilitating 
exploration of SAI of shoulder motor cortex in patient populations.  
 
Intracortical inhibition mediated by GABAergic interneurons within M1 can also be explored 
using TMS. One measure is the cortical silent period (CSP), a transient period of 
electromyography (EMG) suppression following TMS during a voluntary muscle contraction. 
The late period of the CSP is attributed to GABA-mediated intracortical inhibition (Fuhr et 
al., 1991, Inghilleri et al., 1993, Roick et al., 1993, Uncini et al., 1993). Modulation of 
cortical excitability by GABAergic interneurons is critical to the integrity and normal 
function of neural networks (Jacobs and Donoghue, 1991). Aberrant intracortical inhibition 
impacts on cortical reorganisation and motor learning, with negative consequences for 
recovery of function. Accordingly, the CSP is altered in neurological diseases such as 
Parkinson’s and Alzheimer’s disease, Dystonia and Schizophrenia (Khedr et al., Curra et al., 
2011, Lang et al., 2011, Trompetto et al., 2011). The CSP has not been previously described 
in shoulder motor cortex or tested in a chronic shoulder pain population. The CSP may 
elucidate whether GABAergic inhibition within shoulder motor cortex is altered in people 
with chronic pain or if modulation of GABA receptor-mediated inhibition contributes to the 
effect of SSNB. Finally, sensory inputs mediating SAI also modulate GABA receptor-
mediated inhibition, exposed previously by paired-pulse TMS (Udupa et al., 2009, 2014). 
Intracortical inhibition is reduced when SAI is present. The interaction between SAI and 
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GABAergic inhibition has not been explored using the CSP or in shoulder M1 in healthy 
adults or adults experiencing chronic shoulder pain.  
 
The aim of this study was to characterize SAI and CSP in M1 representations of infraspinatus 
in healthy adults, to compare these measures to people experiencing chronic shoulder pain, 
and to determine the impact of SSNB. We formed an a priori hypothesis that SAI and CSP 
are present in healthy adults and SAI attenuates the CSP (Udupa et al., 2009, 2014). Our 
second hypothesis was that SAI is reduced and the CSP lengthened in people with chronic 
shoulder pain. Our third hypothesis was these measures are normalised following SSNB, 
associated with a reduction in subjective pain intensity. These findings will further the 
understanding of cortical neurophysiology in people with chronic shoulder pain and may 




Twenty-six participants included eighteen healthy controls (9 male, 8 female) aged 20-68 
years (mean 41.3), without history of musculoskeletal or neurological conditions affecting the 
upper limb or neck and eight patients with chronic shoulder pain (1 male, 7 female, 49 - 75 
years old, mean 64.9) recruited from a rheumatology clinic. The dominant hand for each 
control participant was determined using the Edinburgh Handedness Inventory (Oldfield, 
1971). All patients had been diagnosed with rotator cuff pathology at least one year prior to 
the study and were identified as suitable candidates for SSNB by the rheumatologist (MS). 
Ethical approval for the study was provided by the local ethics committee and all participants 
provided written informed consent.   
 
2.2 Experimental Design 
Control participants attended a single session to assess cortical neurophysiology. The patients 
attended two sessions, separated by one week. At the first session, baseline TMS measures 
and visual analogue scale (VAS) for pain intensity were collected (PRE), followed by a 
SSNB delivered by the rheumatologist (MS). A second set of measures were taken 30 
minutes later (POST1). Cortical neurophysiology and VAS for pain intensity was assessed 




2.3 Motor Tasks  
Upper limb tasks were used to pre-activate the infraspinatus prior to TMS because MEPs are 
difficult to evoke in this muscle without voluntary activation (Bradnam et al., 2010b). 
Participants were seated with their dominant or painful upper limb positioned in 
approximately 5º of shoulder flexion, 10º of abduction and 45º of external rotation with the 
elbow flexed to 120º and the forearm midway between supination and pronation. The limb 
was supported under the elbow. Prior to testing, participants were trained to perform a 
consistent level of external rotation of the shoulder using visual EMG biofeedback. Activity 
of infraspinatus was carefully monitored by the experimenters by observation of prestimulus, 
root mean square (rms) EMG activity throughout the experiment. Participants were verbally 
encouraged to maintain a consistent contraction. Data were collected over three periods 
separated by a short break (approximately 5 minutes) to prevent muscle fatigue. 
 
2.4 Electromyography  
Surface electromyography (EMG) was recorded from the infraspinatus muscle of the 
dominant upper limb for controls and the affected shoulder in patients. Two 10mm-diamter 
Ag/AgCl adhesive electrodes (Ambu, Ballerp, Denmark) were positioned approximately 3cm 
below the midpoint of the spine of scapula, 1cm apart, and aligned with the direction of 
underlying muscle fibres of the infraspinatus (Roberts et al., 2008, Bradnam et al., 2010b). A 
20mm-diameter Ag/AgCl electrode was fixed over the acromion process as a reference. 
Electrodes were positioned on the upper trapezius and biceps brachii to aid localization of the 
optimum stimulation point for peripheral nerve stimulation (PNS). Electromyography signals 
were sampled at a frequency of 2000Hz (CED1401; UK), amplified and band-pass filtered 
(20-1000Hz) (CED1902; UK) and stored for offline analysis (Signal v 5.07). 
2.5 Transcranial magnetic stimulation 
Single pulse TMS was applied over M1 using a hand-held flat 70mm figure of eight-coil 
Magstim 200² stimulator (Magstim Company, Dyfed, UK). The coil was positioned 
tangentially 45 to the central sulcus over M1 to elicit motor-evoked potentials (MEPs) in the 
infraspinatus muscle (Roberts et al., 2008, Bradnam et al., 2010b, Ngomo et al., 2013). The 
stimulation site evoking the largest amplitude MEP was determined and marked on the head. 
The maximal MEP response (MEPMAX) was obtained and used to establish the stimulus 
intensity (% maximum stimulator output, MSO) to evoke an MEP of approximately half the 
maximal response (50%MEPMAX). Active motor threshold (AMT) was determined as the 
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lowest stimulus intensity producing an MEP above 100uV in five of ten consecutive single 
pulses (Rossini et al., 1994). TMS intensity was set to 120% of AMT and sixteen MEPs were 
recorded to assess corticomotor excitability. To determine SAI and the CSP, PNS was 
delivered prior to TMS using three different ISIs (20, 30 and 40ms) (Hendy et al., 2014). 
Sixteen non-conditioned MEPs were collected along with sixteen conditioned MEPs for each 
ISI, delivered in random order by the computer software (Signal v 5.07, CED, UK).  
 
2.6 Conditioning peripheral nerve stimulation 
A constant current stimulator (DS7A, Digitimer, Hertfordshire, UK) delivered a square wave, 
1-ms duration pulse every 5 seconds via an anode (Ambu, Ballerp, Denmark) positioned on 
the skin over the suprascapular nerve. The nerve was first located using a pen electrode, 
superior and lateral to Erb’s point just above the clavicle (Hendy et al., 2014). Optimum 
anode position was determined by observing an EMG response in the infraspinatus with 
minimal activation of upper trapezius and biceps brachii muscles, to avoid stimulation of 
spinal or musculocutaneous nerves (Figure 1). Stimulus intensity was set to 80% of motor 
threshold to preferentially stimulate group I sensory afferents (Nicolas et al., 2001). 
 
2.7 Data analysis 
Motor EPs were rectified using Signal software (v5.07) and the area measured between the 
MEP onset and offset (MEPAREA). To account for any differences in prestimulus EMG, 
EMGAREA was calculated from the prestimulus EMG over a period equivalent in duration to 
that used to calculate MEPAREA. MEP size was calculated for individual traces using the 
formula: MEPSIZE = (MEPAREA − EMGAREA) × 1000 as described previously (Bradnam et al., 
2010b). The average MEPSIZE was calculated for each individual using the same window 
across time where relevant. A ratio of conditioned to non-conditioned MEPSIZE (C/NC) was 
used to determine SAI at each ISI, so that a ratio of less than one indicated inhibition. To 
determine the duration of the CSP, the period of EMG silence was measured (ms) from the 
stimulus artefact to the point where the unrectified EMG activity returned to 50% of 
prestimulus value (Silbert and Thickbroom, 2013). To determine the influence of SAI on the 
CSP (Udupa et al., 2009), conditioned responses were expressed relative to non-conditioned 
(C/NC) so that a ratio of less than 1 indicated a reduction in CSP (i.e. less inhibition) when 
conditioned by SAI (CSP
SAI
). To determine effect of SSNB in patients, pain scores and 
neurophysiological measures were expressed relative to baseline (post-pre = Δ) and 




2.8 Statistical Analysis 
Statistical analysis was performed using SPSS v14 (IBM). Data were tested for normality 
using the Shapiro-Wilks test. Consistent with our a priori hypothesis, SAI and CSP
SAI
 were 
characterised in control participants for each ISI using one sample t- tests. For both groups, 
ISI was separately compared using repeated measures ANOVA (rmANOVA). Independent 
sample t-tests compared the control and patient (baseline) groups for AMT, MEPSIZE, SAI, 
CSP, CSP
SAI 
and NC MEPs. Prestimulus rmsEMG was compared across conditioned and 
non-conditioned responses and between groups by rmANOVA. In patients, linear regression 
was used to compare baseline pain scores to the neurophysiological variables. To assess the 
effect of SSNB, SAI and CSP
SAI 
were separately analysed using a 3 ISI x 3 TIME rmANOVA. 




NC MEPs (for SAI) were compared using a 3 
TIME (PRE, POST1, POST2) rmANOVA, while AMT at PRE and POST2 was compared 
with a paired t-test. Prestimulus  rmsEMG was tested with a 3 TIME by 4 CONDITION 
(conditioned and non-conditioned responses) rmANOVA. Finally, ∆VAS at POST1 and 
POST2 were compared to ∆SAI and ∆CSP
SAI
 using linear regression. Post hoc paired t-tests 
were used to explore main effects and Bonferroni corrections were applied to multiple 
comparisons. Where data did not conform to sphericity, Greenhouse-Geisser corrections were 




All patients tolerated the nerve block injection and there were no adverse events during TMS 
reported by any participants. Baseline characteristics for patients with chronic shoulder pain 
are provided in Table 1. Figure 2 shows EMG traces of conditioned and non-conditioned 
responses for SAI and CSP in a representative control and shoulder pain patient.  
 
3.1 Characterisation of SAI and CSP in controls 
The one sample t-tests revealed SAI was demonstrated by controls at all ISI’S (ISI20, 0.85 ± 
0.04; ISI30, 0.82 ± 0.059; ISI40 0.83 ± 0.072, all P < 0.03). There was a CSP present in 
controls (mean 98.34 ± 4.6ms) and the CSP was reduced in the presence of SAI (CSP
SAI
) at 
all three ISI’s (ISI20, 0.86 ± 0.014; ISI30, 0.86 ± 0.023; ISI40 0.85 ± 0.026, all P < 0.0001, 
Figure 3). In line with these data, there was no main effect of ISI for SAI or CSP
SAI
 (both P > 
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0.91). Likewise, there was no difference between ISI’s for SAI or CSP
SAI
 in patients (both P > 
0.94), so data were collapsed across ISI for analysis of GROUP. 
 
3.2 Comparison of control and patient groups 
The AMT was higher in patients at baseline (42.38 ± 3.73 MSO) than controls (33.78 ± 2.17 
MSO, P = 0.046, figure 4a). SAI was decreased in patients compared to control participants 
(patients 0.94 ± 0.031; controls 0.83 ± 0.034; F1,73 = 5.73, P = 0.044, figure 4b). The CSP was 
longer in patients (118.03 ± 9.8mm) than controls (98.34 ± 4.6mm, P = 0.048, figure 4c) and 
there was less CSP
SAI
 in patients (0.90 ± 0.012) than controls (0.86 ± 0.013, F1,73 = 3.60, P = 
0.045, figure 4d). The groups did not differ for MEPSIZE (P = 0.25). Non-conditioned MEPs 
used to probe SAI/CSP were similar for both groups (patients 1.84 ± 0.65 mV, controls 1.68 
± 0.25; P = 0.52), as was prestimulus rmsEMG for SAI/CSP (patients 0.028 ± 0.0043mV, 




3.3 Effect of SSNB in patients 
Mean VAS for pain intensity in patients with chronic shoulder pain was 4.4 ± 1.2. There was 
a relationship between VAS pain intensity score and AMT at baseline (R
2
 = 0.71, P = 0.009), 
so that higher pain scores were associated with higher AMT (Figure 5A).There was no 
relationship between VAS and SAI, CSP, CSP
SAI 
 or MEPSIZE at baseline (all P > 0.22). 
Patients reported reduced pain following the SSNB (POST1, 2.9 ± 0.58; POST2, 3.9 ± 0.81), 
but this did not reach statistical significance (P = 0.26, Figure 5b). The rmANOVA for SAI 
revealed no main effects or an interaction (all P > 0.13). Data were collapsed across ISI to 
explore the impact of SSNB. The normalised SAI revealed a main effect of TIME (F2,46  = 
4.23, P = 0.022). Post hoc paired t-tests found SAI was increased from baseline to Post 1 
(Pre, 0.94 ± 0.031; POST1, 0.86 ± 0.021; P = 0.013) and decreased from Post 1 to Post 2 
(POST1, 0.86 ± 0.021; POST2, 0.94 ± 0.028; P = 0.017, Figure 5c). There was no difference 
between baseline and Post 2 (P = 0.86). Data were collapsed across TIME to explore ISI. There 
was no main effect (P = 0.82). For CSP
SAI 
there were no main effects or interactions (all P > 
0.21). Data were collapsed across ISI to explore the impact of SSNB. There was a main effect 
of TIME (F2,46 = 3.91, P = 0.03). Paired t-tests revealed a reduction in CSP
SAI
 between 
baseline and Post 2 (PRE, 0.90 ± 0.12; POST2, 0.95 ± 0.18; P = 0.006) and between Post 1 
and Post 2 (POST1, 0.91± 0.03; POST2, 0.95 ± 0.18; P = 0.047, Figure 5d). Data were 
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collapsed across TIME to further explore ISI. There was no main effect (P = 0.77).There was 
no effect of SSNB for CSP (P = 0.54), AMT (P = 0.72) or MEPSIZE (P = 0.55). The NC 
MEP used to calculate SAI/CSP was consistent (P = 0.52), as was rmsEMG recorded during 
SAI/CSP and MEP collection (both P > 0.49). 
 
There was a positive linear relationship between ΔSAI and ΔVAS at post 1 (R
2
 = 0.57, P = 
0.031), where an increase in SAI was associated with a decrease in pain (Figure 6). There 
was no relationship for ΔSAI and ΔVAS between baseline and post 2 or between post 1 and 
post 2 (both P > 0.23). There was no relationship between ΔCSP
SAI
 and ΔVAS at any time 






The present study investigated short afferent inhibition, the cortical silent period and their 
interactions in shoulder M1 in healthy adults and people experiencing chronic shoulder pain 
before and after a SSNB. There were several findings of interest. First, SAI was demonstrated 
equally at all three ISIs in both participant groups. A CSP was recorded from the 
infraspinatus muscle and was shortened in the presence of SAI in controls. Second, patients 
with shoulder pain demonstrated different cortical neurophysiology compared to controls, 
including reduced SAI, an increased CSP duration and less CSP suppression by SAI in the 
M1 contralateral to the pain affected shoulder. Active motor threshold was higher in patients 
compared to controls and higher AMT in patients was associated with greater pain intensity. 
Third, the SSNB immediately normalised SAI, and an increase in SAI was associated with 
reducted pain intensity, but the effects were transient. Modulation of CSP in the presence of 
SAI, already reduced in patients, was further attenuated one week after the SSNB. The SSNB 
did not influence CSP duration or corticomotor excitability assessed by AMT or MEPSIZE. 
The implications of these findings for understanding cortical contributions to chronic 
shoulder pain and treatment by SSNB are discussed below. 
 
4.1 Afferent inhibition and cortical silent periods in shoulder motor cortex 
Knowledge of the cortical control of proximal muscles in healthy humans is increasing 
(MacKinnon et al., 2004, Alexander et al., 2007, Bradnam et al., 2010a, Bradnam et al., 
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2010b, Alexander, 2011, Bradnam et al., 2011, Perez et al., 2014, Tazoe and Perez, 2014). 
This is the first study to describe sensorimotor integration and characterize cortical silent 
periods in the M1 innervating a proximal upper limb muscle to our knowledge. A CSP of just 
less than 100ms was recorded in the infraspinatus M1 representations in control participants. 
For SAI, the MEP was suppressed by suprascapular nerve stimulation at all three ISIs. The 
observation of SAI at an ISI of 30ms contrasts with our preliminary report in fewer subjects 
(Hendy et al., 2014). The difference may simply be due to greater statistical power in the 
current study. However, the similar effects observed at all ISIs is interesting and warrants 
discussion. Observation of SAI at each ISI may arise from the method used to evoke SAI in 
shoulder motor cortex. By necessity, the infraspinatus muscle must be pre-activated for TMS. 
The degree of SAI assessed from the active infraspinatus (Hendy et al., 2014) is less than that 
reported in resting hand muscle representations but similar to the reduction in SAI prior to 
and during movement to facilitate corticomotor drive to working hand muscles (Voller et al., 
2006, Asmussen et al., 2013). Interestingly, finger muscle contractions attenuate SAI in hand 
M1 (Voller et al., 2006, Asmussen et al., 2013) by modulation of both cortical and spinal 
excitability (Asmussen et al., 2014). The latter finding has implications for our study. If the 
degree of SAI is modulated by the contracting infraspinatus, the question is raised as to 
whether the observed SAI is primarily a cortical or spinal response. Strong support for SAI as 
a cortical phenomenon is provided by the finding of robust CSP attenuation in the presence of 
SAI in healthy adults in the current study, indicating sensory inputs were acting upon cortical 
GABAergic circuits. The CSP duration provides a measure of inhibitory GABAB (Siebner et 
al., 1998) and GABAA receptor-mediated inhibition (Silbert and Thickbroom, 2013). In hand 
muscles, the latter portion of EMG silence is considered a cortical phenomenon (Fuhr et al., 
1990, Inghilleri et al., 1993, Ziemann et al., 1993, Wilson et al., 1995). The significant 
attenuation of the CSP in the presence of SAI observed in the current study indicates neurons 
mediating SAI in M1 suppressed GABAergic inhibitory interneurons. This finding is 
consistent with interactions between SAI and GABA-receptor mediated inhibition using 
paired pulse TMS described in hand motor cortex (Udupa et al., 2009, 2014). In the latter 
studies, short-interval intracortical inhibition (SICI) and long-interval intracortical inhibition 
(LICI), both cortical phenomena, were reduced in the presence of SAI in hand M1. However, 
we cannot rule out that SAI assessed from the contracting infraspinatus muscle is not, at least 
partially, mediated in the spinal cord. There are robust reticulospinal descending pathways to 
spinal motoneurons innervating proximal muscles in the non-human primate (Davidson and 
Buford, 2006, Davidson et al., 2007) and this pathway could increase spinal excitability of 
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the contracting infraspinatus. It might be that descending drive from the reticulospinal tract 
modified the effect of cortically-evoked SAI once that descending volley had reached the 
spinal cord. Such an effect might explain why we observed SAI at all 3 ISIs tested. 
Regardless, our findings for SAI, the CSP and their interactions in shoulder M1 adds to the 
growing understanding of the neural control of the proximal upper limb in healthy adults.   
 
4.2 Comparison of cortical neurophysiology between controls and patients 
There were several differences in TMS-evoked measures between controls and shoulder pain 
patients in the current study. These findings support the presence of aberrant cortical 
neurophysiology in musculoskeletal disorders presenting with pain (Flor, 2003). Our primary 
measure of interest SAI, was reduced in infraspinatus M1 representations in the chronic pain 
group compared to controls. While the reason for reduced SAI in patients cannot be 
determined from the current study, we suggest it might result from lower activity in 
inhibitory projections from S1 to M1 interneurons mediating SAI. It is known that S1 
excitability is important for normal SAI, as in healthy adults repetitive TMS to suppress S1 
reduced SAI in hand motor cortex (Tsang et al., 2014). It is also known that primary sensory 
cortex is suppressed by acute nociceptive afferent input (Schabrun et al., 2013). If chronic 
pain also produces ongoing S1 suppression, then S1 drive to M1 circuits mediating SAI 
would be reduced in turn attenuating the SAI response. While this idea is speculative, it is 
known that activity in S1 is modulated by peripheral inputs and S1 modulation is closely 
associated with M1 excitability (Schabrun et al., 2012). The aberrant mechanisms may also 
include a reduction in brain acetylcholine levels as SAI is decreased or abolished in the 
presence of acetylcholine blockers (Knikou, 2008), or an increase in levels of GABA, also 
known to reduce SAI (Di Lazzaro et al., 2005).  
 
The latter mechanism is supported by our finding that the CSP was lengthened in chronic 
shoulder pain patients compared to controls, indicating an increase in GABA-receptor 
mediated inhibition. An increase in GABAergic inhibition has implications for recovery of 
motor function in conditions presenting with chronic pain (Boudreau et al., 2010), as a 
reduction in GABA receptor-mediated inhibition is necessary for cortical reorganization and 
motor learning (Perez et al., 2004; Stagg et al., 2011). Furthermore, suppression of the CSP 
by SAI was deficient in patients, indicating a reduction of the modulatory effect of sensory 
inputs on intracortical GABA circuits in chronic shoulder pain. The mechanism to explain 
this observation could be that activity in SAI interneurons is too weak to influence the 
14 
 
stronger GABA inhibitory circuits or the increase in GABA receptor-mediated inhibition is of 
such magnitude that it cannot be suppressed by SAI. Regardless, the impact in patients with 
chronic shoulder pain is disruption in cortical control of a crucial dynamic stabilizer of the 
glenohumeral joint, potentially exacerbating shoulder pathology and impeding functional 
recovery. 
 
Motor thresholds were higher in patients than controls in the current study, in agreement with 
previous findings in chronic shoulder pain (Alexander, 2007, Berth et al., 2009) and between 
painful and non-painful hemispheres in patients (Ngomo et al., 2014). Motor threshold 
reflects intrinsic neuronal membrane excitability dependent upon metabolically driven ion 
pumps and ion channel conductivity (Ziemann et al., 1996). Pain may affect these cellular 
mechanisms and raise depolarization threshold. Interestingly, higher active thresholds were 
associated with pain intensity in the current study; in contrast to a previous study where 
higher thresholds were associated with pain duration (Ngomo et al., 2014). There was no 
difference in MEP amplitude, normalized for background muscle activity, between groups in 
the current study. This finding differs from a previous report where corticomotor excitability 
of the contracting deltoid muscle in people with a rotator cuff injury was reduced in 
comparison to healthy controls (Berth et al., 2009). However, in agreement with our study, 
people with chronic rotator cuff tendinopathy had no difference in corticomotor excitability 
between hemispheres controlling the painful and painless shoulders (Ngomo et al., 2014). 
Furhtermore, in that study cortical maps were no different in each hemisphere. Cortical 
reorganisation has been observed in other musculoskeletal pain conditions such as persistent 
elbow pain (Schabrun et al., 2014) and recurrent low back pain (Tsao et al., 2008, Tsao et al., 
2011). These data suggest AMT along with SAI and the CSP could provide biomarkers and 
cortical targets for future interventions for chronic shoulder pain rather than corticomotor 
excitability assessed by MEP amplitude. 
 
The SSNB has been found to reduce pain in chronic musculoskeletal and post-stroke shoulder 
pain (Shanahan et al., 2003, Shanahan et al., 2004, Adey-Wakeling et al., 2013), although we 
did not observe a longer term effect in the current study. Therapeutic benefits might be due to 
an influence of the SSNB at the level of the cortex by an increase in cortical excitability 
(Brasil-Neto et al., 1993). In the current study, SAI was increased immediately following 
SSNB and was associated with less pain. These findings indicate reduced nociceptive 
afference may have driven restoration of SAI, possibly by influencing excitability of S1. If 
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the SSNB transiently reversed S1 suppression so that cortico-cortical drive to M1 
interneurons mediating SAI was restored SAI would normalise, as we observed in our 
patients. However, the effect of the SSNB was short-lived as SAI was attenuated again at one 
week follow up. Therefore, an increase in SAI cannot explain ongoing therapeutic benefits of 
SSNB reported in clinical populations. There was no change in corticomotor excitability after 
the SSNB, in contrast to a previous report where corticomotor excitability was increased 
immediately following a forearm nerve block (Brasil-Neto et al., 1993). However, that study 
was conducted in healthy participants with normal cortical function. Intracortical inhibition 
was increased in our chronic shoulder pain group, which may have prevented an increase in 
corticomotor excitability. In support, SSNB did not reduce the longer CSP in patients in the 
current study, indicating SSNB does not influence GABA receptor-mediated inhibition in 
M1. This finding agrees with those in healthy adults where an ischaemic nerve block did not 
reduce  GABAergic intracortical inhibition measured by paired-pulse TMS (Vallence et al., 
2012). The effect of a nerve block on the cortex does not appear to include direct 
modification of GABA inhibitory circuits. In contrast, the modulation of CSP by SAI in 
shoulder M1 may be influenced by the SSNB. While modulation of CSP by SAI was 
unaffected immediately after SSNB (when SAI was normalised), reduced suppression of the 
CSP by SAI in patients was further attenuated one week later (when SAI had reverted to 
baseline). This finding indicates SSNB may affect the longer term interaction between 
GABAergic and SAI circuitry within M1 by an independent and unknown mechanism. 
Further exploration of inhibitory interactions in shoulder motor cortex may be useful to 
explain longer term clinical benefits of SSNB for chronic shoulder pain. The lack of any 
other robust finding at the one week follow up means it is likely cortical mechanisms 
underlying longer term effects are outside of those currently investigated and future studies 
should investigate other TMS measures. 
 
5. Limitations 
There are several limitations to the study. First, the patient cohort and healthy controls were 
not age and gender matched and the average age of the control group was much younger than 
the shoulder pain group. Therefore, difference in cortical neurophysiology may be associated 
with aging as well as pain. This can be explored further using a carefully age and gender 
matched control group. Second, the chronic shoulder pain group was likely underpowered to 
detect all effects of SSNB, and while all had diagnosed rotator cuff pathology of greater than 
one year, the mechanism of injury, specific diagnosis and duration of symptoms was not 
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standardised. Third, by chance this cohort had relatively low pain scores at baseline providing 
a smaller margin for change and limiting application to the wider population. However, the 
current findings indicate a larger, fully powered study in a homogeneous group of chronic 
shoulder pain patients is warranted. Finally, future studies should investigate cortical 
neurophysiology in both hemispheres, as proximal muscles are known to be bilaterally 
controlled (Bradnam et al., 2010a, Bradnam et al., 2010b, Bradnam et al., 2011, 
McCambridge et al., 2011) and differences in some cortical measures between hemispheres 
have been reported in chronic shoulder pain (Ngomo et al., 2014). 
 
6.Conclusions 
Sensorimotor integration, intracortical inhibition and their interactions can be studied in 
infraspinatus motor cortex by pairing TMS and suprascapular nerve stimulation. Deficits in 
cortical function were identified in people experiencing chronic shoulder pain compared to 
controls in the current study, where intracortical inhibitory mechanisms were aberrant.  Short 
term clinical effects of a suprascapular nerve block might be explained by modulation of 
sensorimotor integration, while longer term effects might be related to interactions between 
inputs from somatosensory cortex and inhibitory GABA circuits within M1. The SSNB did 
not influence active motor thresholds or the cortical silent period, two neurophysiological 
markers that differentiated patients from controls. It may be of value to assess the effect of 
other interventions for shoulder pain on these cortical biomarkers. Further studies using 
larger numbers of homogeneous patients and a wider range of TMS measures are needed to 
further elucidate the effects of SSNB in chronic shoulder pain. 
 
Conflict of Interest 
None of the authors have potential conflicts of interest to be disclosed 
 
Acknowledgement 
The authors would like to thank Dr Sebastian Doeltgen and Dr Christine Barry for insightful 
comments during preparation of this manuscript. This study was supported by the Discipline 
of Physiotherapy Flinders University and the Department of Rheumatology, Repatriation 




Adey-Wakeling Z, Crotty M, Shanahan EM (2013) Suprascapular nerve block for shoulder 
pain in the first year after stroke: a randomized controlled trial. Stroke 44:3136-3141. 
Alexander C, Miley R, Stynes S, Harrison PJ (2007) Differential control of the 
scapulothoracic muscles in humans. J Physiol 580:777-786. 
Alexander CM (2007) Altered control of the trapezius muscle in subjects with non-traumatic 
shoulder instability. Clin Neurophysiol 118:2664-2671. 
Alexander CM (2011) Shoulder girdle control; some mechanisms of function to dysfunction. 
Man Ther 16:42-43. 
Arwert HJ, de Groot J, Van Woensel WW, Rozing PM (1997) Electromyography of shoulder 
muscles in relation to force direction. J Shoulder and Elbow surgery 6:360-370. 
Asmussen MJ, Jacobs MF, Lee KGH, Zapallow CM, Nelson AJ (2013) Short-latency afferent 
inhibition modulation during finger movement. PloS One 8:1-9. 
Asmussen MJ, Zapallow CM, Jacobs MF, Lee KGH, Tsang P, Nelson AJ (2014) Modulation 
of Short-Latency Afferent Inhibition Depends on Digit and Task-Relevance. PloS 
One 9:1-12. 
Berth A, Pap G, Neuman W, Awiszus F (2009) Central neuromuscular dysfunction of the 
deltoid muscle in patients with chronic rotator cuff tears. J Orthop & Trauma 10:135-
141. 
Berth A, Pap G, Neumann W (2010) Altered neuromuscular control of a hand muscle in 
chronic rotator cuff tears. Arch Orthop Trauma Surg 130:705-710. 
Boudreau SA, Farina D, Falla D (2010) The role of motor learning and neuroplasticity in 
designing rehabilitation approaches for musculoskeletal pain disorders. Man Ther 
15:410-414. 
Bradnam LV, Stinear CM, Byblow WD (2010a) Theta burst stimulation of human primary 
motor cortex degrades selective muscle activation in the ipsilateral arm. J 
Neurophysiol 104:2594-2602. 
Bradnam LV, Stinear CM, Byblow WD (2011) Cathodal transcranial direct current 
stimulation suppresses ipsilateral projections to presumed propriospinal neurons of 
the proximal upper limb. J Neurophysiol 105:2582-2589. 
Bradnam LV, Stinear CM, Lewis GN, Byblow WD (2010b) Task-dependent modulation of 
inputs to proximal upper limb following transcranial direct current stimulation of 
primary motor cortex. J Neurophysiol 103:2382-2389. 
Brasil-Neto JP, Valls-Sole J, Pascual-Leone A, Cammarota A, Amassian VE, Cracco R, 
Maccabee P, Cracco J, Hallett M, Cohen LG (1993) Rapid modulation of human 
cortical motor outputs following ischaemic nerve block. Brain 116 ( Pt 3):511-525. 
Chen R, Corwell B, Hallett M (1999) Modulation of motor cortex excitability by median 
nerve and digit stimulation. Exp Brain Res 129:77-86. 
Curra A, Coppola G, Gorini M, Porretta E, Bracaglia M, Di Lorenzo C, Schoenen J, F. P 
(2011) Drug induced changes in cortical inhibition in medication overuse headache. 
Cephalalgia 31:309-327. 
Davidson AG, Buford JA (2006) Bilateral actions of the reticulospinal tract on arm and 
shoulder muscles in the monkey: stimulus triggered averaging. Exp Brain Res 173:25-
39. 
Davidson AG, Schieber MH, Buford JA (2007) Bilateral spike-triggered average effects in 
arm and shoulder muscles from the monkey pontomedullary reticular formation. J 
Neurosci 27:8053-8058. 
Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell 
JC (2000) Muscarinic receptor blockade has differential effects on the excitability of 
intracortical circuits in the human motor cortex. Exp Brain Res 135:455-461. 
18 
 
Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci 
G, Fiorilla T, Tonali P (2005) Effects of lorazepam on short latency afferent inhibition 
and short latency intracortical inhibition in humans. J Physiol 564:661-668. 
Di Lazzaro V, Oliviero A, Tonali P, Marra MD, Daniele A, Profice P, Saturno E, Pilato F, 
Masullo C, Rothwell JC (2002) Noninvasive in vivo assessment of cholinergic 
cortical circuits in AD using transcranial magnetic stimulation. Neurology 59:392-
397. 
Di Lazzaro V, Profice P, Pilato F, Capone F, Ranieri F, Florio L, Colosimo C, Pravata E, 
Pasqualetti P, Dileone M (2012) The level of cortical afferent inhibition in acute 
stroke correlated with long-term functional recovery in humans. Stroke 43:250-252. 
Flor H (2003) Cortical reorganisation and chronic pain: implications for rehabilitation. J 
Rehab Med 41:66-72. 
Fuhr P, Agostino R, Hallett M (1991) Spinal motor neuron excitability during the silent 
period after cortical stimulation. Electroenceph Clin Neurophysiol 81:257-262. 
Gill TK, Shanahan EM, Taylor AW, Buchbinder R, Hill CL (2013) Shoulder pain in the 
community: an examination of associative factors using a longitudinal cohort study. 
Arthritis Care & Res 65:2000-2007. 
Hendy KA, Visser A, Hordacre B, Bradnam LV (2014) Afferent inhibition of infraspinatus 
primary motor cortex by stimulation of the suprascapular Nerve. Brain stimulation. 
Hill CL, Gill TK, Shanahan EM, Taylor AW (2010) Prevalence and correlates of shoulder 
pain and stiffness in a population-based study: the North West Adelaide health study. 
Int J Rheum Dis 13:215-222. 
Inghilleri M, Berardelli A, Cruccu G, Manfredi M (1993) Silent period evoked by 
transcranial magnetic stimulation of the human cortex and cervicomedullary junction. 
J Physiol 466. 
Jacobs KM, Donoghue JP (1991) Reshaping the cortical motor map by unmasking latent 
intracortical connections. Science 251:944-947. 
Khedr EM, Ahmed MA, Darwish ES, ali AM The relationship between motor cortex 
excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation 
study. Neurophysiologie clinique = Clinical neurophysiology 41:107-113. 
Knikou M (2008) the H-reflex as a probe: pathways and pitfalls. J Neurosci Meth 171:1-12. 
Krause P, Foerderreuther S, Straube A (2004) Bilateral motor cortex disinhibition in complex 
regional pain syndrome (CRPS) type I of the hand. Neurology 62:1654. 
Krause P, Forderreuther S, Straube A (2006) TMS motor cortical brain mapping in patients 
with complex regional pain syndrome type I. Clin Neurophysiol 117:169-176. 
Lang S, Stopsack M, Kotchoubey B, Frick C, Grave HJ, Spitzer C, Barnow S (2011) Cortical 
inhibition in alexithymic patients with borderline personality disorder. Biolog Pysch 
88:227-232. 
MacKinnon CD, Quartarone A, Rothwell JC (2004) Inter-hemispheric asymmetry of 
ipsilateral corticofugal projections to proximal muscles in humans. Exp Brain Res 
157:225-233. 
Magarey ME, Jones MA (2003) Dynamic evaluation and early management of altered motor 
control around the shoulder complex. Man Ther 8:195-206. 
McCambridge AB, Bradnam LV, Stinear CM, Byblow WD (2011) Cathodal transcranial 
direct current stimulation of the primary motor cortex improves selective muscle 
activation in the ipsilateral arm. J Neurophysiol 105:2937-2942. 
Ngomo S, Mercier C, Bouyer LJ, Savoie A, Roy JS (2014) Alterations in central motor 




Ngomo S, Mercier C, Roy JS (2013) Cortical mapping of the infraspinatus muscle in healthy 
individuals. BMC Neurosci 14:52. 
Nicolas G, Marchand-Pauvert V, Burke D, Pierrot-Deseilligny E (2001) Cortico- spinal 
excitation of presumed cervical propriospinal neurones and its rever- sal to inhibition 
in humans. J Physiol 533:903-919. 
Oldfield RC (1971) The assessment and analysis of handedness: The Edinburgh inventory. 
Neuropsychologia 9:97-113. 
Perez MA, Butler JE, Taylor JL (2014) Modulation of transcallosal inhibition by bilateral 
activation of agonist and antagonist proximal arm muscles. J Neurophysiol 111:405-
414. 
Pope DP, Croft PR, Pritchard CM, Silman AJ (1997) Prevalence of shoulder pain in the 
community: the influence of case definition. Ann Rheum Dis 56:308-312. 
Roberts LV, Stinear CM, Lewis GN, Byblow WD (2008) Task-dependent modulation of 
propriospinal inputs to human shoulder. J Neurophysiol 100:2109-2114. 
Roick H, von Giesen HJ, Benecke R (1993) On the origin of the postexcitatory inhibition 
seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain 
Research 94:489-498. 
Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, 
Hallett M, Katayama Y, Lucking CH, et al. (1994) Non-invasive electrical and 
magnetic stimulation of the brain, spinal cord and roots: basic principles and 
procedures for routine clinical application. Report of an IFCN committee. 
Electroenceph & clin neurophysiol 91:79-92. 
Sailer A, Molnar GF, Paradiso G, Gunraj C, Lang AE, Chen R (2003) Short and long latency 
afferent inhibition in Parkinson's disease. Brain 126:1883-1894. 
Schabrun SM, Hodges PW, Vicenzino B, Jones E, Chipchase LS (2014) Novel adaptions in 
motor cortical maps: the relationship to peristent elbow pain. J Am Col Sports Med 1-
31. 
Schabrun SM, Jones E, Kloster J, Hodges PW (2013) Temporal association between changes 
in primary sensory cortex and corticomotor output during muscle pain. Neuroscience 
235:159-164. 
Schabrun SM, Ridding MC, Galea MP, Hodges PW, Chipchase LS (2012) Primary sensory 
and motor cortex excitability are co-modulated in response to peripheral electrical 
nerve stimulation. PloS One 7:e51298. 
Shanahan EM, Ahern MA, Smith M, Wetherall M, Bresnihan B, FitzGerald O (2003) 
Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in 
chronic shoulder pain. Ann Rheum Dis 62:400-406. 
Shanahan EM, Shanahan KR, Hill CL, Ahern MJ, Smith MD (2012) Safety and acceptability 
of suprascapular nerve block in rheumatology patients. Clin Rheumatol 31:145-149. 
Shanahan EM, Smith MD (2012) The safety of suprascapular nerve block. Reg Anesth & 
Pain Med 37:120-121. 
Shanahan EM, Smith MD, Wetherall M, Lott CW, Slavotinek J, FitzGerald O, Ahern MJ 
(2004) Suprascapular nerve block in chronic shoulder pain: are the radiologists better? 
Ann Rheum Dis 63:1035-1040. 
Siebner HR, Dressnandt J, Auer C, Conrad B (1998) Continuous intrathecal baclofen 
infusions induced a marked increase of the transcranially evoked silent period in a 
patient with generalized dystonia. Muscle & Nerve 21:1209-1212. 
Silbert BI, Thickbroom GW (2013) Conditioning the cortical silent period with paired 
transcranial magnetic stimulation. Brain Stim 6:541-544. 
Tazoe T, Perez MA (2014) Selective activation of ipsilateral motor pathways in intact 
humans. J Neurosci 34:13924-13934. 
20 
 
Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Massone P, Tonali 
P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by 
somatosensory input from the hand. J Physiol 532:503-513. 
Trompetto C, Avanzino L, Marinelli L, Mori L, Pelosin E, Roccatagliata L, Abbruzzese G 
(2011) Corticospinal excitability in patients with secondary dystonia due to focal 
lesions of the basal ganglia and thalamus. Clin Neurophysiol 9. 
Tsang P, Jacobs MF, Lee GH, Asmussen MJ, Zapallow CM, Nelson AJ (2014) Continuous 
theta-burst stimulation over primary somatosensory cortex modulates short-latency 
afferent inhibition. Clin Neurophysiol 125:2253-2259. 
Tsao H, Danneels LA, Hodges PW (2011) ISSLS prize winner: Smudging the motor brain in 
young adults with recurrent low back pain. Spine 36:1721-1727. 
Tsao H, Galea MP, Hodges PW (2008) Reorganization of the motor cortex is associated with 
postural control deficits in recurrent low back pain. Brain. 131:2161-2171. 
Turton AJ, McCabe CS, Harris N, Filipovic SR (2007) Sensorimotor integration in Complex 
Regional Pain Syndrome: a transcranial magnetic stimulation study. Pain 127:270-
275. 
Udupa K, Ni Z, Gunraj C, Chen R (2009) Interactions between short latency afferent 
inhibition and long interval inracortical inhibition. Exp Brain Res 199:177-183. 
Udupa K, Ni Z, Gunraj C, Chen R (2014) Effects of short-latency afferent inhibition on short-
interval intracortical inhibition. J Neurophysiol 111:1350-1361. 
Uncini A, Treviso M, Di Muzio A, Simone P, Pullman S (1993) Physiological basis of 
voluntary activity inhibition induced by transcranial cortical stimulation. 
Electroenceph & Clin Neurophysiol 89:211-220. 
Vallence AM, Reilly K, Hammond G (2012) Excitability of intracortical inhibitory and 
facilitatory circuits during ischemic nerve block. Rest Neurol & Neurosci 30:345-354. 
Voller B, St Clair Gibson A, Dambrosia J, Pirio Richardson S, Lomarev M, Dang N, Hallett 
M (2006) Short-latency afferent inhibition during selective finger movement. Exp 
Brain Res 169:226-231. 
Wilson SA, Lockwood RJ, Thickbroom GM, Mastaglia FL (1995) An investigation of the 
late excitatory potential in the hand following magnetic stimulation of the motor 
cortex. Electroenceph & Clin Neurophysiol 97:55-62. 
Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW, Galna B, Burn DJ 
(2013) Short latency afferent inhibition: a biomarker for mild cognitive impairment in 
Parkinson's disease? Mov Dis 28:1285-1288. 
Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996) Effects of antiepileptic drugs on 
motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann 
Neurol 40:367-378. 
Ziemann U, Netz J, Szelenyi A, Homberg V (1993) Spinal and supraspinal mechanisms 
contribute to the silent period in the contracting soleus muscle after transcranial 







Figure 1. Location of the suprascapular nerve for peripheral nerve stimulation. The 
suprascapular nerve was located superiorly and laterally from Erb’s point (B). The anode was 
positioned on the skin overlying the suprascupular nerve (A) and the cathode over the 
clavicle (C).  
 
Figure 2. Electromyography traces showing condition and non-conditioned MEPs used to 
calculate SAI and CSPs in A. a representative control participant and B. a chronic shoulder 
pain patient. The onset of the CSP is indicated by the arrow. Smaller MEPs and shorter CSPs 
are noted for conditioned responses compared to non-conditioned responses in controls but 
not patients. 
 
Figure 3. A. SAI and B. CSP
SAI
 in control participants. There was SAI and CSP
SAI
 at all three 
ISIs. Significance with one sample t-test is signified by asterisks (*). There was no difference 
between ISIs for either measure (both P > 0.91). 
 
Figure 4. A comparison between control and patient participants. A. AMT, B. SAI, C. CSP, 
D. CSP
SAI
. The significant difference between groups is signified by asterisks (*) at P < 0.05. 
 
Figure 5. A. The relationship between AMT and self-reported pain at baseline in patients. B. 
Effect of SSNB on SAI, C. Effect of SSNB on CSP, D. Effect of SSNB on CSP
SAI
.  
Significance differences are signified by asterisks (*) at P < 0.05. 
 
Figure 6. The relationship between a reduction in pain at POST1 and an increase in SAI, 
where restoration of SAI was associated with greater pain reduction.  
 
Table 1. Characteristics of patients with chronic shoulder pain. 
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